| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Amyotrophic lateral sclerosis | 9 | 4 | |
| General health | 7 | 9 | |
| Parkinson's disease | 6 | 2 | |
| Fatigue | 4 | 1 | |
| Myalgic encephalomyelitis/chronic fatigue syndrome | 4 | 3 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Eye muscle twitching (fasciculations) | 1 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 1 | |
| Mild | 1 | |
| None | 19 |
Member evaluations
nacona
evaluated on Nov 01, 2015
- Perceived effectiveness for amyotrophic lateral sclerosis: Slight
- Side effects: None
Dawn Angel
evaluated on Jan 28, 2012
- Perceived effectiveness for Support brain health: Can't tell
- Side effects: None
NMAPLM
evaluated on Mar 07, 2011
- Perceived effectiveness for attention deficit/hyperactivity disorder: Moderate
- Side effects: None